1. Home
  2. NOTV vs RBOT Comparison

NOTV vs RBOT Comparison

Compare NOTV & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • RBOT
  • Stock Information
  • Founded
  • NOTV 1974
  • RBOT 2014
  • Country
  • NOTV United States
  • RBOT United States
  • Employees
  • NOTV N/A
  • RBOT N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • RBOT Medical Specialities
  • Sector
  • NOTV Health Care
  • RBOT Health Care
  • Exchange
  • NOTV Nasdaq
  • RBOT Nasdaq
  • Market Cap
  • NOTV 57.7M
  • RBOT 61.4M
  • IPO Year
  • NOTV 1997
  • RBOT N/A
  • Fundamental
  • Price
  • NOTV $1.69
  • RBOT $6.11
  • Analyst Decision
  • NOTV Strong Buy
  • RBOT Hold
  • Analyst Count
  • NOTV 1
  • RBOT 1
  • Target Price
  • NOTV $5.00
  • RBOT $7.00
  • AVG Volume (30 Days)
  • NOTV 429.6K
  • RBOT 36.5K
  • Earning Date
  • NOTV 08-06-2025
  • RBOT 08-12-2025
  • Dividend Yield
  • NOTV N/A
  • RBOT N/A
  • EPS Growth
  • NOTV N/A
  • RBOT N/A
  • EPS
  • NOTV N/A
  • RBOT N/A
  • Revenue
  • NOTV $505,299,000.00
  • RBOT N/A
  • Revenue This Year
  • NOTV $5.64
  • RBOT N/A
  • Revenue Next Year
  • NOTV $5.16
  • RBOT N/A
  • P/E Ratio
  • NOTV N/A
  • RBOT N/A
  • Revenue Growth
  • NOTV 0.85
  • RBOT N/A
  • 52 Week Low
  • NOTV $1.15
  • RBOT $5.00
  • 52 Week High
  • NOTV $6.48
  • RBOT $19.00
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 41.79
  • RBOT 36.35
  • Support Level
  • NOTV $1.65
  • RBOT $5.89
  • Resistance Level
  • NOTV $1.85
  • RBOT $6.91
  • Average True Range (ATR)
  • NOTV 0.13
  • RBOT 0.74
  • MACD
  • NOTV -0.01
  • RBOT -0.11
  • Stochastic Oscillator
  • NOTV 8.33
  • RBOT 4.77

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About RBOT Vicarious Surgical Inc.

Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.

Share on Social Networks: